This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Spherix To Present Newest Work On Lipoproteins And Atheromas At Pittcon, The World's Largest Annual Expo For Laboratory Science

BETHESDA, Md., March 8, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – announces that Dr. Robert Lodder, Company President, will be making two presentations at the Pittcon Conference to be held March 11-15 in Orlando, FL, at the Orlando Convention Center.  Dr. Lodder's presentations discuss two of Spherix's pipeline products and potential indications for use in treating heart disease, dyslipidemia and metabolic syndrome.  They are:
  • March 12, 2012 – "Molecular Factor Computing (MFC) of the Extent of Atherosclerosis in D‑Tagatose Treatment," in Room 308D at 3:35 p.m.
  • March 15, 2012 – "Measurement of Lipoproteins in Treatment with SPX-106," in Room 308C at 10:15 a.m.

MFC uses new high speed integrated computational imaging (ICI) techniques to simplify trials and measure arterial characteristics like reduction in atherosclerotic lesion area with D-tagatose administration quickly and accurately.  Other blood vessel anomalies like abdominal aortic aneurysm (AAA), which is often correlated to atherosclerosis, can also be quickly identified and measured.  In genetically engineered mice, substitution of tagatose in the diet for sucrose significantly reduced lesion area (p<0.001) in mice over a 16-week study.  MFC of macrophage activity and collagen content was also conducted (see Figure 1).

Lipoprotein measurements conducted using fast protein liquid chromatography (FPLC), enzymatic methods, near-infrared and infrared spectrometry show statistically significant reductions (p<0.05) in VLDL, LDL and HDL when SPX106 is administered over 8 weeks with D-tagatose.  LDL and oxLDL are correlated to expression of tissue inhibitor of metalloproteinase-1 (TIMP-1), an endogenous inhibitor of MMPs, in human vascular endothelial cells.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs